FDA halts use of antibody drugs that don’t work vs. Omicron.
FDA halts use of antibody drugs that don’t work vs. omicron – Associated Press Related: Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
The post FDA halts use of antibody drugs that don’t work vs. Omicron. appeared first on Links Medicus.
Despite the ongoing spread of Omicron, some European countries have decided to lift Covid-19 restrictions.
England lifts COVID restrictions as omicron threat recedes – Associated Press Denmark confirms plan to lift Covid-19 restrictions on February 1st – The Local dk Netherlands lifts toughest Covid curbs with Denmark and France set to follow – The Guardian Denmark will lift nearly ALL Covid restrictions within days and return to ‘life as we […]
The post Despite the ongoing spread of Omicron, some European countries have decided to lift Covid-19 restrictions. appeared first on Links Medicus.
ELSO Guidelines for anticoagulation in adult and pediatric patients using extracorporeal membrane oxygenation (ECMO).
2021 ELSO Adult and Pediatric Anticoagulation Guidelines – ASAIO Journal Commentary on Twitter The updated @ELSOOrg adult & pediatric anticoagulation guidelines just out, open access, on @asaiojournal?anticoagulants?therapeutic monitoring of anticoagulants?management of bleeding & thrombotic complications#FOAMcc #FOAMecmo #PedsICU? https://t.co/sC8iQK6YL0 pic.twitter.com/hkbVoNBDkR — ELSO (@ELSOOrg) January 21, 2022
The post ELSO Guidelines for anticoagulation in adult and pediatric patients using extracorporeal membrane oxygenation (ECMO). appeared first on Links Medicus.
After Omicron, some scientists foresee ‘a period of quiet’.
After Omicron, some scientists foresee ‘a period of quiet’ – Science
The post After Omicron, some scientists foresee ‘a period of quiet’. appeared first on Links Medicus.
Perspective | Where do we stand with Omicron? The data, the math, the patterns, and the exit.
Where do we stand with Omicron? – by Dr. Eric Topol Commentary on Twitter Where do we stand with Omicron?I've summarized the new data, math, patterns, and potential exit ramphttps://t.co/SyCmCzkBQX @SubstackInc — Eric Topol (@EricTopol) January 22, 2022
The post Perspective | Where do we stand with Omicron? The data, the math, the patterns, and the exit. appeared first on Links Medicus.
Clinical characteristics and outcomes of patients with COVID-19–Associated Acute Respiratory Distress Syndrome who underwent lung transplant.
Clinical Characteristics and Outcomes of Patients With COVID-19–Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant – JAMA Related: Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.
The post Clinical characteristics and outcomes of patients with COVID-19–Associated Acute Respiratory Distress Syndrome who underwent lung transplant. appeared first on Links Medicus.
RCT: Hyperimmune immunoglobulin did not improve outcomes in hospitalized patients with COVID-19.
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial – The Lancet Commentaries: High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19 – The Lancet Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19 – NIH News Releases
The post RCT: Hyperimmune immunoglobulin did not improve outcomes in hospitalized patients with COVID-19. appeared first on Links Medicus.
Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.
Lung Transplantation for Covid-19–Related Respiratory Failure in the United States – New England Journal of Medicine Commentaries: New data on COVID-19 lung transplants – Cedars-Sinai Medical Center ~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure – HealthDay
The post Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%. appeared first on Links Medicus.
Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant – New England Journal of Medicine Commentary: Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds – University of Wisconsin-Madison Commentary on Twitter Investigators assessed the in vitro activities of seven monoclonal antibodies & three antiviral drugs against […]
The post Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective. appeared first on Links Medicus.
Comprehensive review of chest tube management.
Comprehensive Review of Chest Tube Management – JAMA Surgery (free for a limited period)
The post Comprehensive review of chest tube management. appeared first on Links Medicus.